Diapositive PPT

30

20

10

0

10

20

30

40

Lamivudine 100 mg

Placebo

50

2

3

*

39

6

*

11

2

47

17

*p<0.01 compared to placebo

15

27

0

15

Improved

Patients

(%)

Worsened

34

4

Lai

Dienstag

Tassopoulos

Heathcote

Schiff

19

7

• Ranked assessment of changes in liver fibrosis

• ITTm population: patients lacking either biopsy excluded

• All treatment arms for 52 weeks

Traitement de l'hépatite B Lamivudine: réduction de la fibrose